Up-regulation of miR-592 correlates with tumor progression and poor prognosis in patients with colorectal cancer

Biomedicine and Pharmacotherapy

Volumn 69, Issue , 2015, Pages 214-220

  Liu, Mulin ^a   Zhi, Qiaoming ^b   Wang, Wenbin ^c   Zhang, Qiao ^d   Fang, Taotao ^d   Ma, Qingyong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d BENGBU MEDICAL COLLEGE   (China)

Author keywords

Colorectal cancer; MiR 592; Prognosis; Progression

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MICRORNA; MICRORNA 592; UNCLASSIFIED DRUG; MIRN592 MICRORNA, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR INVASION; TUMOR VOLUME; UPREGULATION; WOUND HEALING; AGED; BLOOD; COLORECTAL TUMOR; DISEASE COURSE; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; STAINING; SURVIVAL; TUMOR CELL LINE;

AGED; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; STAINING AND LABELING; SURVIVAL ANALYSIS; TUMOR STEM CELL ASSAY; UP-REGULATION; WOUND HEALING;

EID: 84922259962     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.12.001     Document Type: Article

References (27)

1. Pourhoseingholi M.A. Increased burden of colorectal cancer in Asia. World J Gastrointest Oncol 2012, 4:68-70.
2. Yeoh K.G., Ho K.Y., Chiu H.M., Zhu F., Ching J.Y., Wu D.C., et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 2011, 60:1236-1241.
3. Giovannucci E. Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. J Womens Health (Larchmt) 2003, 12:173-182.
4. Migliore L., Migheli F., Spisni R., Coppede F. Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol 2011, 2011:792362.
5. Schee K., Lorenz S., Worren M.M., Gunther C.C., Holden M., Hovig E., et al. Deep sequencing the MicroRNA transcriptome in colorectal cancer. PLoS One 2013, 8:e66165.
6. Funaioli C., Longobardi C., Martoni A.A. The impact of chemotherapy on overall survival and quality of life of patients with metastatic colorectal cancer: a review of phase III trials. J Chemother 2008, 20:14-27.
7. Kusenda B., Mraz M., Mayer J., Pospisilova S. MicroRNA biogenesis, functionality and cancer relevance. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006, 150:205-215.
8. Bueno M.J., Perez de Castro I., Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle 2008, 7:3143-3148.
9. Tufekci K.U., Meuwissen R.L., Genc S. The role of microRNAs in biological processes. Methods Mol Biol 2014, 1107:15-31.
10. Cho W.C. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007, 6:60.
11. Shah M.Y., Calin G.A. MicroRNAs as therapeutic targets in human cancers. Wiley Interdiscip Rev RNA 2014, 5:537-548.
12. Wang W., Zhao L.J., Tan Y.X., Ren H., Qi Z.T. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis 2012, 33:1113-1120.
13. Kim J., Lim N.J., Jang S.G., Kim H.K., Lee G.K. miR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung. Anticancer Res 2014, 34:2297-2302.
14. Irmady K., Jackman K.A., Padow V.A., Shahani N., Martin L.A., Cerchietti L., et al. Mir-592 regulates the induction and cell death-promoting activity of p75NTR in neuronal ischemic injury. J Neurosci 2014, 34:3419-3428.
15. Peng X.H., Huang H.R., Lu J., Liu X., Zhao F.P., Zhang B., et al. MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma. Mol Cancer 2014, 13:186.
16. Duan J.H., Fang L. MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR. Tumour Biol 2014, 35:11013-11019.
17. Muller V., Gade S., Steinbach B., Loibl S., von Minckwitz G., Untch M., et al. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial. Breast Cancer Res Treat 2014, 147:61-68.
18. Orang A.V., Barzegari A. MicroRNAs in colorectal cancer: from diagnosis to targeted therapy. Asian Pac J Cancer Prev 2014, 15:6989-6999.
19. Ye J.J., Cao J. MicroRNAs in colorectal cancer as markers and targets: recent advances. World J Gastroenterol 2014, 20:4288-4299.
20. Oberg A.L., French A.J., Sarver A.L., Subramanian S., Morlan B.W., Riska S.M., et al. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One 2011, 6:e20465.
21. Boisen M.K., Dehlendorff C., Linnemann D., Nielsen B.S., Larsen J.S., Osterlind K., et al. Tissue MicroRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line capecitabine and oxaliplatin with or without bevacizumab. PLoS One 2014, 9:e109430.
22. Eccles S.A., Welch D.R. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007, 369:1742-1757.
23. Geiger T.R., Peeper D.S. Metastasis mechanisms. Biochim Biophys Acta 2009, 1796:293-308.
24. Lacatena M., Comes P., Argese A.V., Leo S. Diagnostic value of CEA in neoplasms of the colon and rectum. Review of cases. Minerva Chir 1989, 44:1021-1023.
25. Sablin M.P., Italiano A., Spano J.P. Colorectal cancers: prognostic and predictive factors of response to treatment. Bull Cancer 2009, 96:417-423.
26. Zlobec I., Lugli A. Prognostic and predictive factors in colorectal cancer. Postgrad Med J 2008, 84:403-411.
27. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.